income tax refund loans

Alkermes, Inc.(NASDAQ: ALKS) today announced financial results for its third quarter of fiscal 2008. Financial highlights for the quarter ended December 31, 2007 include: -- Sixth consecutive profitable quarter on a GAAP basis, with net income of $168. 9 million. Net income for the third quarter included proceeds from the sale of the company's stake in Reliant Pharmaceuticals, Inc.-- Quarterly revenues of $50. 8 million. Worldwide sales of RISPERDAL(R) CONSTA(R) by Janssen were $295. 1 million for the third quarter of fiscal 2008 and over $1. 1 billion for the calendar year ended December 31, 2007.-- Positive cash flow in the quarter and the first nine months of the fiscal year; cash and total investments of $516. interest loan mortgage only texas kiddie condo loan loans held for sale business loan non traditional